decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / 220.6.10
Subscribe or sign in to view the full article.
Article Overview
This page covers Medicare’s national coverage policy for FDG PET use in breast cancer and explains the scope, timing, and documentation context of the guidance. It is aimed at coders, billers, clinicians, and compliance staff who need to understand the coverage framework, related limitations, and when the policy became effective.
Why This Topic Matters
Coverage policy articles like this help determine whether a service falls within Medicare’s nationally covered circumstances and identify situations that remain outside the policy. That makes the page relevant for medical coding, claims review, utilization management, and documentation support.
What You Will Learn
- The Medicare coverage scope for FDG PET in breast cancer
- The effective date of the coverage guidance
- The types of breast cancer scenarios addressed by the policy
- The stated limitations on national coverage
- The documentation context referenced by the manual
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Clinicians ordering imaging studies
- Utilization management staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com